

TAVR –
THERAPY OVERVIEW
TAVR enables replacement of a diseased aortic valve through a catheter-based procedure. It is an established treatment option for selected patients with severe symptomatic aortic stenosis and is performed following clinical assessment and Heart Team decision-making.
Patients in LANDMARK
Participating Centers
Countries
Patients in COMPARE-TAVI
PROCEDURE
TAVR follows a carefully planned catheter-based sequence, from vascular access to valve deployment and post-implant assessment. Each stage is guided by imaging and procedural planning to support accurate positioning and valve performance.





MERIL TAVR SOLUTIONS
Meril’s TAVR portfolio brings together transcatheter heart valve technology designed to support procedural precision, anatomical fit and consistent valve performance across diverse patient anatomies.
CLINICAL EVIDENCE
The Myval™ THV Series is supported by a growing body of clinical evidence across randomized trials, prospective studies, registries and real-world experience, evaluating procedural performance and clinical outcomes in TAVR.
Randomized clinical evidence evaluating the Myval™ THV Series against contemporary transcatheter heart valve platforms.
Prospective studies and registries contributing to the broader evidence base across diverse patient populations.
A randomized clinical program expanding comparative evidence across transcatheter aortic valve technologies.
TAVR EDUCATION



EXPLORE TAVR SOLUTIONS
Explore Meril’s range of transcatheter heart valve technologies and supporting solutions designed to address diverse anatomical and procedural needs across the TAVR journey.